Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table

The COMEX-30 hyperbaric treatment table is used to manage decompression sickness in divers but may result in pulmonary oxygen toxicity (POT). Volatile organic compounds (VOCs) in exhaled breath are early markers of hyperoxic stress that may be linked to POT. The present study assessed whether VOCs f...

Full description

Bibliographic Details
Main Authors: Feiko J. M. de Jong, Thijs T. Wingelaar, Paul Brinkman, Pieter-Jan A. M. van Ooij, Anke H. Maitland-van der Zee, Markus W. Hollmann, Rob A. van Hulst
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/3/316
_version_ 1797610223183069184
author Feiko J. M. de Jong
Thijs T. Wingelaar
Paul Brinkman
Pieter-Jan A. M. van Ooij
Anke H. Maitland-van der Zee
Markus W. Hollmann
Rob A. van Hulst
author_facet Feiko J. M. de Jong
Thijs T. Wingelaar
Paul Brinkman
Pieter-Jan A. M. van Ooij
Anke H. Maitland-van der Zee
Markus W. Hollmann
Rob A. van Hulst
author_sort Feiko J. M. de Jong
collection DOAJ
description The COMEX-30 hyperbaric treatment table is used to manage decompression sickness in divers but may result in pulmonary oxygen toxicity (POT). Volatile organic compounds (VOCs) in exhaled breath are early markers of hyperoxic stress that may be linked to POT. The present study assessed whether VOCs following COMEX-30 treatment are early markers of hyperoxic stress and/or POT in ten healthy, nonsmoking volunteers. Because more oxygen is inhaled during COMEX-30 treatment than with other treatment tables, this study hypothesized that VOCs exhaled following COMEX-30 treatment are indicators of POT. Breath samples were collected before and 0.5, 2, and 4 h after COMEX-30 treatment. All subjects were followed-up for signs of POT or other symptoms. Nine compounds were identified, with four (nonanal, decanal, ethyl acetate, and tridecane) increasing 33–500% in intensity from before to after COMEX-30 treatment. Seven subjects reported pulmonary symptoms, five reported out-of-proportion tiredness and transient ear fullness, and four had signs of mild dehydration. All VOCs identified following COMEX-30 treatment have been associated with inflammatory responses or pulmonary diseases, such as asthma or lung cancer. Because most subjects reported transient pulmonary symptoms reflecting early-stage POT, the identified VOCs are likely markers of POT, not just hyperbaric hyperoxic exposure.
first_indexed 2024-03-11T06:11:29Z
format Article
id doaj.art-a220f76671b44a09887e72f25b1feabb
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T06:11:29Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-a220f76671b44a09887e72f25b1feabb2023-11-17T12:35:46ZengMDPI AGMetabolites2218-19892023-02-0113331610.3390/metabo13030316Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment TableFeiko J. M. de Jong0Thijs T. Wingelaar1Paul Brinkman2Pieter-Jan A. M. van Ooij3Anke H. Maitland-van der Zee4Markus W. Hollmann5Rob A. van Hulst6Royal Netherlands Navy Diving and Submarine Medical Centre, 1780 CA Den Helder, The NetherlandsRoyal Netherlands Navy Diving and Submarine Medical Centre, 1780 CA Den Helder, The NetherlandsDepartment of Pulmonology, Amsterdam UMC, Location AMC, 1100 DD Amsterdam, The NetherlandsRoyal Netherlands Navy Diving and Submarine Medical Centre, 1780 CA Den Helder, The NetherlandsDepartment of Pulmonology, Amsterdam UMC, Location AMC, 1100 DD Amsterdam, The NetherlandsDepartment of Anesthesiology, Amsterdam UMC, Location AMC, 1100 DD Amsterdam, The NetherlandsDepartment of Anesthesiology, Amsterdam UMC, Location AMC, 1100 DD Amsterdam, The NetherlandsThe COMEX-30 hyperbaric treatment table is used to manage decompression sickness in divers but may result in pulmonary oxygen toxicity (POT). Volatile organic compounds (VOCs) in exhaled breath are early markers of hyperoxic stress that may be linked to POT. The present study assessed whether VOCs following COMEX-30 treatment are early markers of hyperoxic stress and/or POT in ten healthy, nonsmoking volunteers. Because more oxygen is inhaled during COMEX-30 treatment than with other treatment tables, this study hypothesized that VOCs exhaled following COMEX-30 treatment are indicators of POT. Breath samples were collected before and 0.5, 2, and 4 h after COMEX-30 treatment. All subjects were followed-up for signs of POT or other symptoms. Nine compounds were identified, with four (nonanal, decanal, ethyl acetate, and tridecane) increasing 33–500% in intensity from before to after COMEX-30 treatment. Seven subjects reported pulmonary symptoms, five reported out-of-proportion tiredness and transient ear fullness, and four had signs of mild dehydration. All VOCs identified following COMEX-30 treatment have been associated with inflammatory responses or pulmonary diseases, such as asthma or lung cancer. Because most subjects reported transient pulmonary symptoms reflecting early-stage POT, the identified VOCs are likely markers of POT, not just hyperbaric hyperoxic exposure.https://www.mdpi.com/2218-1989/13/3/316hyperbaric oxygen therapyhyperoxiapulmonary oxygen toxicityexhaled breath markersvolatile organic compoundsCOMEX-30
spellingShingle Feiko J. M. de Jong
Thijs T. Wingelaar
Paul Brinkman
Pieter-Jan A. M. van Ooij
Anke H. Maitland-van der Zee
Markus W. Hollmann
Rob A. van Hulst
Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table
Metabolites
hyperbaric oxygen therapy
hyperoxia
pulmonary oxygen toxicity
exhaled breath markers
volatile organic compounds
COMEX-30
title Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table
title_full Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table
title_fullStr Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table
title_full_unstemmed Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table
title_short Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table
title_sort analysis of volatile organic compounds in exhaled breath following a comex 30 treatment table
topic hyperbaric oxygen therapy
hyperoxia
pulmonary oxygen toxicity
exhaled breath markers
volatile organic compounds
COMEX-30
url https://www.mdpi.com/2218-1989/13/3/316
work_keys_str_mv AT feikojmdejong analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable
AT thijstwingelaar analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable
AT paulbrinkman analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable
AT pieterjanamvanooij analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable
AT ankehmaitlandvanderzee analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable
AT markuswhollmann analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable
AT robavanhulst analysisofvolatileorganiccompoundsinexhaledbreathfollowingacomex30treatmenttable